Lipothera

Lipothera is a South Korean biotechnology company specializing in non-invasive therapeutic solutions for metabolic diseases, particularly obesity and non-alcoholic steatohepatitis (NASH/MASH). The company utilizes a proprietary High-Intensity Focused Ultrasound (HIFU) platform to selectively target and treat visceral fat and liver steatosis. Their lead program, LPT-101, is a clinical-stage device designed to reduce abdominal visceral fat, offering a non-surgical alternative for obesity management. Additionally, Lipothera is advancing LPT-102, which explores the application of focused ultrasound for the treatment of liver inflammation and fat accumulation. By providing a targeted, non-pharmacological approach, Lipothera aims to address the global burden of metabolic disorders with a favorable safety profile.